Zacks Small Cap Research – MTVA: Positive Phase 1 MAD Data for DA-1726; Excellent Tolerability Profile and Mean Day 26 Weight Loss of 4.3%… – Go Health Pro

Zacks Small Cap Research – MTVA: Positive Phase 1 MAD Data for DA-1726; Excellent Tolerability Profile and Mean Day 26 Weight Loss of 4.3%… – Go Health Pro

By David Bautz, PhD NASDAQ:MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Positive Phase 1 MAD Data for DA-1726 On April 15, 2025, MetaVia Inc. (NASDAQ:MTVA) announced positive results from the Phase 1 Part 2 multiple ascending dose (MAD) trial of DA-1726 in obesity. The results showed that the cohort receiving 32 mg of … Read more

Amazon’s RTO delays exemplify why workers get so mad about mandates – Go Health Pro

Amazon’s RTO delays exemplify why workers get so mad about mandates – Go Health Pro

Concern about RTO planning is underscored by Amazon reportedly lacking enough space for its current in-office policy. Bloomberg said that “in recent interviews, employees complained of working from shared desks, crowded corporate canteens, and a lack of conference rooms for confidential calls or team meetings.” The publication also pointed to employee displeasure with having to … Read more